These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34216264)

  • 21. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
    Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS
    Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amantadine in the treatment of Parkinson's disease. New opportunities in the context of COVID-19].
    Katunina EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(4):101-106. PubMed ID: 34037362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of home confinement during COVID-19 pandemic on Parkinson's disease.
    Kumar N; Gupta R; Kumar H; Mehta S; Rajan R; Kumar D; Kandadai RM; Desai S; Wadia P; Basu P; Mondal B; Sanchita ; Rawat A; Meka SS; Mishal B; Prashanth LK; Srivastava AK; Goyal V
    Parkinsonism Relat Disord; 2020 Nov; 80():32-34. PubMed ID: 32937224
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair.
    Vivekanantham S; Shah S; Dewji R; Dewji A; Khatri C; Ologunde R
    Int J Neurosci; 2015; 125(10):717-25. PubMed ID: 25364880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
    Speeckaert MM; Speeckaert R; Delanghe JR
    Mov Disord; 2020 Sep; 35(9):1497. PubMed ID: 33400280
    [No Abstract]   [Full Text] [Related]  

  • 26. Research in motion: the enigma of Parkinson's disease pathology spread.
    Brundin P; Li JY; Holton JL; Lindvall O; Revesz T
    Nat Rev Neurosci; 2008 Oct; 9(10):741-5. PubMed ID: 18769444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review.
    Jaiswal V; Alquraish D; Sarfraz Z; Sarfraz A; Nagpal S; Singh Shrestha P; Mukherjee D; Guntipalli P; Sánchez Velazco DF; Bhatnagar A; Savani S; Halilaj E; Ruxmohan S; Cueva W
    J Prim Care Community Health; 2021; 12():21501327211039709. PubMed ID: 34404266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic neurons degenerate by apoptosis in Parkinson's disease.
    Hirsch EC; Hunot S; Faucheux B; Agid Y; Mizuno Y; Mochizuki H; Tatton WG; Tatton N; Olanow WC
    Mov Disord; 1999 Mar; 14(2):383-5. PubMed ID: 10091646
    [No Abstract]   [Full Text] [Related]  

  • 29. Behind the Mask: Recognizing Facial Features of Parkinson's Disease During the COVID-19 Pandemic.
    Soares C; Carneiro DR; Dias R; Ferreira D; Sousa M; Oliveira A; Massano J; Morgadinho A; Rosas MJ; Araújo R
    Mov Disord; 2021 Jun; 36(6):1285-1286. PubMed ID: 33834516
    [No Abstract]   [Full Text] [Related]  

  • 30. Reply to the letter "SARS-CoV-2 cannot unmask Parkinson's disease if there was none before infection".
    Calculli A; Bocci T; Priori A; Pisani A
    Eur J Neurol; 2023 Sep; 30(9):2948. PubMed ID: 37335886
    [No Abstract]   [Full Text] [Related]  

  • 31. [Is leuko-araiosis in Alzheimer's disease, in Parkinson's disease and in healthy elderly persons the result of Wallerian degeneration?].
    Leys D; Pruvo JP; Soetaert G; Vermersch P; Rapoport A; Clarisse J; Petit H
    Acta Neurol Belg; 1989; 89(3-4):249-52. PubMed ID: 2516973
    [No Abstract]   [Full Text] [Related]  

  • 32. Technology insight: imaging neurodegeneration in Parkinson's disease.
    Brooks DJ
    Nat Clin Pract Neurol; 2008 May; 4(5):267-77. PubMed ID: 18382437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reply to: Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
    Cereda E; Fasano A; Pezzoli G
    Mov Disord; 2020 Sep; 35(9):1498. PubMed ID: 33400277
    [No Abstract]   [Full Text] [Related]  

  • 34. What can Parkinson's disease teach us about COVID-19?
    Tipton PW; Wszolek ZK
    Neurol Neurochir Pol; 2020; 54(2):204-206. PubMed ID: 32323862
    [No Abstract]   [Full Text] [Related]  

  • 35. SARS-CoV-2 Vaccines and Motor Symptoms in Parkinson's Disease.
    Cosentino C; Torres L; Vélez M; Nuñez Y; Sánchez D; Armas C; Alvarado M
    Mov Disord; 2022 Jan; 37(1):233. PubMed ID: 34775612
    [No Abstract]   [Full Text] [Related]  

  • 36. Covid Proof Self-Management Training for Caregivers of Patients with Parkinson's Disease.
    Duits AA; Boots LMM; Mulders AEP; Moonen AJH; Vugt ME
    Mov Disord; 2021 Mar; 36(3):529-530. PubMed ID: 33368615
    [No Abstract]   [Full Text] [Related]  

  • 37. SARS-CoV-2 cannot unmask Parkinson's disease if there was none before infection.
    Finsterer J; Scorza FA
    Eur J Neurol; 2023 Sep; 30(9):2946-2947. PubMed ID: 37310296
    [No Abstract]   [Full Text] [Related]  

  • 38. Parkinson's disease following COVID-19: causal link or chance occurrence?
    Li WS; Chan LL; Chao YX; Tan EK
    J Transl Med; 2020 Dec; 18(1):493. PubMed ID: 33375935
    [No Abstract]   [Full Text] [Related]  

  • 39. Researcher's study whether Parkinson's disease impacts body mass index.
    Naccari C
    CNS Spectr; 2003 May; 8(5):338. PubMed ID: 12778904
    [No Abstract]   [Full Text] [Related]  

  • 40. Favourable course in a cohort of Parkinson's disease patients infected by SARS-CoV-2: a single-centre experience.
    Buccafusca M; Micali C; Autunno M; Versace AG; Nunnari G; Musumeci O
    Neurol Sci; 2021 Mar; 42(3):811-816. PubMed ID: 33439387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.